You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cancer, Multiple Myeloma (MM), Relapsed or Refractory Multiple Myeloma (R/R MM), pharmacokinetics

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Worldwide (Cevostamab, Tocilizumab)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +17 more
Jan 23, 2023

Multiple Myeloma Trial in Worldwide (RO7425781)

Recruiting
  • Multiple Myeloma
  • North Melbourne, Victoria, Australia
  • +15 more
Jan 19, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Multiple Myeloma of Bone Trial in Worldwide (HPN217)

Recruiting
  • Multiple Myeloma in Relapse
  • +3 more
  • Gilbert, Arizona
  • +17 more
Jul 21, 2022

Relapsed or Refractory Multiple Myeloma Trial (Cevostamab, Elranatamab, Tocilizumab)

Not yet recruiting
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Jun 22, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Anti-GPRC5D CAR-T Cells Injection)

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • Anti-GPRC5D CAR-T Cells Injection
  • (no location specified)
Feb 18, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial in Kunming (Anti-GPRC5D CAR-T cells infusion)

Recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • Anti-GPRC5D CAR-T cells infusion
  • Kunming, Yunnan, China
  • +1 more
Feb 21, 2023

Multiple Myeloma, Plasma Cell Leukemia Trial in Shanghai (Human BCMA targeted CAR-NK cells injection)

Recruiting
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • Human BCMA targeted CAR-NK cells injection
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Sep 13, 2023

Refractory Multiple Myeloma, Relapse Multiple Myeloma, Multiple Myeloma Trial in Boston (Elranatamab)

Not yet recruiting
  • Refractory Multiple Myeloma
  • +2 more
  • Boston, Massachusetts
  • +2 more
Nov 17, 2023

Relapsed/ Refractory Multiple Myeloma Trial (GC012F)

Not yet recruiting
  • Relapsed/ Refractory Multiple Myeloma
  • GC012F
  • (no location specified)
Apr 28, 2023

Relapsed/Refractory Multiple Myeloma Trial in Japan (ABBV-383)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Kashiwa-shi, Chiba, Japan
  • +5 more
Jan 25, 2023

Multiple Myeloma, Non-Hodgkin Lymphoma, B-Cell Lymphoma Trial in Korea, Republic of, United States (Tiragolumab,

Active, not recruiting
  • Multiple Myeloma
  • +2 more
  • Denver, Colorado
  • +12 more
Jan 19, 2023

Multiple Myeloma Trial in Beijing (melphalan HCl for injection)

Recruiting
  • Multiple Myeloma
  • melphalan hydrochloride for injection
  • Beijing, Beijing, China
    Peking University People's Hospital
Jun 26, 2022

Multiple Myeloma, Relapsed Hematologic Malignancy Trial in Seattle (Digital Health Coaching Program, Fitbit)

Recruiting
  • Multiple Myeloma
  • Relapsed Hematologic Malignancy
  • Digital Health Coaching Program
  • Fitbit
  • Seattle, Washington
    University of Washington
Jul 13, 2023

Medicine Called Elranatamab in People With Relapsed Refractory

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jun 30, 2023

Multiple Myeloma Trial in Canton (Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Canton, Ohio
    Gabrail Cancer & Research Center
Oct 11, 2023

Relapsed/Refractory Multiple Myeloma Trial in China (LBL-034 for Injection)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • LBL-034 for Injection
  • Wuhu, Anhui, China
  • +6 more
Sep 24, 2023

Advanced Solid Tumors, Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Multiple Myeloma Trial in Gyeonggi-do,

Recruiting
  • Advanced Solid Tumors
  • +2 more
  • GIC-102 (Allogeneic NK cells)
  • Gyeonggi-do, Korea, Republic of
  • +3 more
May 18, 2023

Multiple Myeloma Trial (AZD0305)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 24, 2023

Multiple Myeloma Trial in Athens (Cevostamab, XmAb24306, Tocilizumab)

Recruiting
  • Multiple Myeloma
  • Athens, Greece
  • +1 more
Jan 2, 2023

Multiple Myeloma Trial in Shanghai, Wenzhou (Human BCMA Targeted T Cells Injection)

Recruiting
  • Multiple Myeloma
  • Human BCMA Targeted T Cells Injection
  • Shanghai, Shanghai, China
  • +1 more
Dec 7, 2022

Multiple Myeloma Trial (CM313 injection)

Not yet recruiting
  • Multiple Myeloma
  • CM313 injection
  • (no location specified)
Nov 6, 2023

Learn How Triple Class Refractory Multiple Myeloma Are Treated

Not yet recruiting
  • Relapse Multiple Myeloma
  • Refractory Multiple Myeloma
    • (no location specified)
    Feb 15, 2023

    Relapsed or Refractory Multiple Myeloma Trial in Beijing (Mitoxantrone Hydrochloride Liposome injection, Bortezomib for

    Recruiting
    • Relapsed or Refractory Multiple Myeloma
    • Mitoxantrone Hydrochloride Liposome injection
    • +2 more
    • Beijing, Beijing, China
      Beijing Chaoyang Hospital, Capital Medical University
    Jan 16, 2022

    Relapsed/Refractory Multiple Myeloma, Relapsed/Refractory DLBCL Trial in United States (EZM0414)

    Recruiting
    • Relapsed/Refractory Multiple Myeloma
    • Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    • Chevy Chase, Maryland
    • +10 more
    Jan 12, 2023

    Multiple Myeloma Trial in Shanghai (Human Derived anti-BCMA CAR-T Injection)

    Recruiting
    • Multiple Myeloma
    • Human Derived anti-BCMA CAR-T Injection
    • Shanghai, Shanghai, China
      Shanghai Changzheng Hospital
    Mar 27, 2022